Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04231747
Title A Study of CC-97540, CD19-targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Juno Therapeutics, a Subsidiary of Celgene

diffuse large B-cell lymphoma

follicular lymphoma

marginal zone B-cell lymphoma

B-cell lymphoma

primary mediastinal B-cell lymphoma



Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.